Variables | Overall (n = 208) | Without RH (n = 166) | With RH (n = 42) | P for trend |
---|---|---|---|---|
Age (years) | 55.7 ± 12.3 | 53.2 ± 11.4 | 59.3 ± 10.1 | 0.018 |
Male, n (%) | 136 (65.4) | 104 (62.7) | 32 (76.2) | < 0.001 |
Smoking, n (%) | 127 (61.1) | 100 (60.2) | 27 (64.3) | 0.037 |
BMI (Kg/m2) | 24.4 ± 3.2 | 23.3 ± 2.8 | 24.9 ± 3.0 | 0.87 |
Duration of hypertension (years) | 5.4 ± 3.3 | 4.0 ± 2.1 | 6.5 ± 3.7 | 0.022 |
Diabetes, n (%) | 38 (18.3) | 30 (18.1) | 8 (19.0) | 0.51 |
CRP (mg/L) | 19.3 ± 6.5 | 15.2 ± 5.4 | 24.7 ± 5.0 | < 0.001 |
TC (mmol/L) | 5.2 ± 1.1 | 5.1 ± 1.0 | 5.3 ± 1.1 | 0.63 |
LDL-C (mmol/L) | 3.6 ± 0.8 | 3.5 ± 0.9 | 3.6 ± 0.7 | 0.66 |
HDL-C (mmol/L) | 1.1 ± 0.3 | 1.0 ± 0.2 | 1.1 ± 0.5 | 0.57 |
TG (mmol/L) | 1.8 ± 0.4 | 1.8 ± 0.5 | 1.7 ± 0.3 | 0.49 |
Creatinine (μmol/l) | 116.9 ± 12.74 | 110.2 ± 10.56 | 120.7 ± 9.86 | 0.28 |
BUN (mmol/L) | 6.6 ± 2.4 | 6.7 ± 2.0 | 6.3 ± 2.2 | 0.43 |
Lp-PLA2 activity (nmol/min/mL) | 230.5 ± 26.4 | 228.1 ± 24.5 | 254.2 ± 26.7 | < 0.001 |
Official SBP (mm Hg) | 140.7 ± 10.4 | 132.4 ± 5.5 | 147.3 ± 3.6 | < 0.001 |
Official DBP (mm Hg) | 87.6 ± 5.9 | 82.3 ± 4.4 | 94.4 ± 2.6 | < 0.001 |
24 h mean SBP (mm Hg) | 134.5 ± 5.6 | 126.3 ± 4.9 | 137.7 ± 6.2 | < 0.001 |
24 h mean DBP (mm Hg) | 83.3 ± 4.8 | 76.8 ± 2.4 | 86.5 ± 4.7 | < 0.001 |
Heart rate (beats per minute) | 81.4 ± 11.5 | 78.7 ± 10.3 | 88.2 ± 9.0 | < 0.001 |
Number of anti-hypertensive medicines | 3.4 ± 0.5 | 3.3 ± 0.4 | 3.5 ± 0.4 | 0.65 |
ACEI/ARB, n (%) | 167 (80.3) | 135 (81.3) | 32 (76.2) | 0.044 |
CCB, n (%) | 115 (55.3) | 89 (53.6) | 26 (61.9) | 0.037 |
Beta-blocker, n (%) | 87 (41.8) | 69 (41.2) | 18 (42.9) | 0.71 |
Diuretic, n (%) | 186 (89.4) | 144 (86.7) | 42 (100) | < 0.001 |
Alpha-blocker, n (%) | 45 (21.6) | 36 (21.7) | 9 (21.4) | 0.83 |
Statins, n (%) | 105 (50.5) | 89 (53.6) | 16 (38.1) | < 0.001 |
Aspirin, n (%) | 167 (80.3) | 135 (81.3) | 32 (76.2) | 0.058 |